MLPRX Stock Overview
Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastics worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Parx Materials N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.29 |
52 Week High | €0.66 |
52 Week Low | €0.24 |
Beta | 0.20 |
1 Month Change | -21.62% |
3 Month Change | -34.09% |
1 Year Change | -27.50% |
3 Year Change | -87.39% |
5 Year Change | -96.33% |
Change since IPO | -91.88% |
Recent News & Updates
Recent updates
Shareholder Returns
MLPRX | FR Chemicals | FR Market | |
---|---|---|---|
7D | 0% | -0.9% | -0.03% |
1Y | -27.5% | 13.6% | 1.8% |
Return vs Industry: MLPRX underperformed the French Chemicals industry which returned 13.7% over the past year.
Return vs Market: MLPRX underperformed the French Market which returned 1.7% over the past year.
Price Volatility
MLPRX volatility | |
---|---|
MLPRX Average Weekly Movement | 16.4% |
Chemicals Industry Average Movement | 5.6% |
Market Average Movement | 4.4% |
10% most volatile stocks in FR Market | 9.7% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: MLPRX's share price has been volatile over the past 3 months.
Volatility Over Time: MLPRX's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | n/a | Michael van der Jagt | www.parxmaterials.com |
Parx Materials N.V. engages in the manufacture and sale of antibacterial/antimicrobial plastics worldwide. The company offers its products for food contact applications and food packaging; implants and medical devices; textiles; pipes and drainages; and anti-fouling applications, as well as to contamination, biofilm, and moulds. It holds a patented technology under the Saniconcentrate name.
Parx Materials N.V. Fundamentals Summary
MLPRX fundamental statistics | |
---|---|
Market cap | €2.66m |
Earnings (TTM) | -€164.01k |
Revenue (TTM) | €128.21k |
20.8x
P/S Ratio-16.2x
P/E RatioIs MLPRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MLPRX income statement (TTM) | |
---|---|
Revenue | €128.21k |
Cost of Revenue | €77.60k |
Gross Profit | €50.61k |
Other Expenses | €214.63k |
Earnings | -€164.01k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.018 |
Gross Margin | 39.48% |
Net Profit Margin | -127.93% |
Debt/Equity Ratio | 0% |
How did MLPRX perform over the long term?
See historical performance and comparison